Drugs / 608
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06242652 | Mar 2024 → Feb 2025 | ankylosing spondylitis | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 608 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06242652 ↗ |
| Route | Subcutaneous | “608 subcutaneous (SC) injection.” NCT06242652 ↗ |